We believe that dedication to our end users, both patients and clinicians, is the key to developing lasting technological and workflow improvements to healthcare. We strive for simplicity, robustness, and intuitiveness as foundational elements of all our imaging solutions in order to delight all who touch our technology.
This showed previously unseen and information-rich cardiac activity in a subject without any contact or energization required—a feat previously reserved for Science Fiction TV and Movies. The discovery was one of many brand-new clinical insights using the body's own energy as an indicator of health. Baule and McFee's novel insights blossomed into the field of biomagnetism.
Magnetocardiography’s technical and clinical development has been primarily driven by Superconducting Quantum Interference Devices (SQUID). MCG hardware has evolved steadily from single channel laboratory-based investigational devices, to high-density commercially available units.
Through always focusing on our end users and constantly scanning disciplines across science and technology, we are delivering powerful new tools to clinicians.
Genetesis receives FDA 510(k) clearance for its cardiac imaging platform. The platform pairs the CardioFlux™ Magnetocardiograph with the integrated Faraday Analytical Cloud™ (FAC).
Device is evaluated in a pilot clinical protocol studying the value of magnetocardiography in chest pain triage.
If you join the team, you’ll hear over and over how we operate from “first principles”. These values are what that really means.
Meet the three founders who first saw the potential for MCG to change how patients experience cardiac care.
Co-Founder & CEO
Peeyush has 8 years of experience as a serial medical technology entrepreneur and technologist. He currently serves as the Co-Founder and Chief Executive Officer of Genetesis, where he has raised over $25 million in venture capital financing and led the company...
Co-Founder & CEO
Vineet is a proven product focused executive, specializing in full lifecycle medical device development and commercial access. As Co-Founder and Chief Operations Officer of Genetesis, he is highly adept at technical and corporate strategy implementation...
Co-Founder & CEO
Emmanuel is a highly technical co-founder and technical strategist with having had a background in software development and IT operation for nearly 10 years. He currently serves as the Co-founder and Chief Technology Officer of Genetesis, where he has been responsible...
Peeyush Shrivastava
Co-Founder and CEO of Genetesis